热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易

客户端

　　中科生物（01237）发布公告，截至2024年12月31日止年度，集团预期将取得股东应占净利润约人民币300万元（2023年：净亏损人民币240万元）。

　　集团实现扭亏为盈，主要由于集团上一年度所得税开支的超额拨备拨回约人民币880万元。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.